vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and Clearfield, Inc. (CLFD). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $34.3M, roughly 1.1× Clearfield, Inc.). CODEXIS, INC. runs the higher net margin — 24.7% vs -1.8%, a 26.5% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -3.2%). CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $-2.4M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -3.5%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.

CDXS vs CLFD — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.1× larger
CDXS
$38.9M
$34.3M
CLFD
Growing faster (revenue YoY)
CDXS
CDXS
+84.5% gap
CDXS
81.3%
-3.2%
CLFD
Higher net margin
CDXS
CDXS
26.5% more per $
CDXS
24.7%
-1.8%
CLFD
More free cash flow
CDXS
CDXS
$22.0M more FCF
CDXS
$19.6M
$-2.4M
CLFD
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-3.5%
CLFD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CDXS
CDXS
CLFD
CLFD
Revenue
$38.9M
$34.3M
Net Profit
$9.6M
$-614.0K
Gross Margin
94.8%
33.2%
Operating Margin
27.1%
-5.3%
Net Margin
24.7%
-1.8%
Revenue YoY
81.3%
-3.2%
Net Profit YoY
192.5%
67.8%
EPS (diluted)
$0.13
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
CLFD
CLFD
Q4 25
$38.9M
$34.3M
Q3 25
$8.6M
$23.4M
Q2 25
$15.3M
$49.9M
Q1 25
$7.5M
$47.2M
Q4 24
$21.5M
$29.7M
Q3 24
$12.8M
$5.6M
Q2 24
$8.0M
$48.8M
Q1 24
$17.1M
$36.9M
Net Profit
CDXS
CDXS
CLFD
CLFD
Q4 25
$9.6M
$-614.0K
Q3 25
$-19.6M
$-9.1M
Q2 25
$-13.3M
$1.6M
Q1 25
$-20.7M
$1.3M
Q4 24
$-10.4M
$-1.9M
Q3 24
$-20.6M
Q2 24
$-22.8M
$-447.0K
Q1 24
$-11.5M
$-5.9M
Gross Margin
CDXS
CDXS
CLFD
CLFD
Q4 25
94.8%
33.2%
Q3 25
71.3%
53.2%
Q2 25
86.3%
30.5%
Q1 25
63.8%
30.1%
Q4 24
83.0%
29.2%
Q3 24
66.4%
Q2 24
56.6%
21.9%
Q1 24
71.6%
7.7%
Operating Margin
CDXS
CDXS
CLFD
CLFD
Q4 25
27.1%
-5.3%
Q3 25
-220.3%
10.3%
Q2 25
-83.9%
3.0%
Q1 25
-271.6%
0.6%
Q4 24
-34.2%
-6.9%
Q3 24
-129.0%
Q2 24
-284.9%
-4.7%
Q1 24
-69.6%
-26.4%
Net Margin
CDXS
CDXS
CLFD
CLFD
Q4 25
24.7%
-1.8%
Q3 25
-228.1%
-38.8%
Q2 25
-86.6%
3.2%
Q1 25
-274.3%
2.8%
Q4 24
-48.4%
-6.4%
Q3 24
-160.8%
Q2 24
-285.2%
-0.9%
Q1 24
-67.4%
-16.0%
EPS (diluted)
CDXS
CDXS
CLFD
CLFD
Q4 25
$0.13
$-0.04
Q3 25
$-0.22
$-0.65
Q2 25
$-0.16
$0.11
Q1 25
$-0.25
$0.09
Q4 24
$-0.12
$-0.13
Q3 24
$-0.29
Q2 24
$-0.32
$-0.04
Q1 24
$-0.16
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
CLFD
CLFD
Cash + ST InvestmentsLiquidity on hand
$78.2M
$96.4M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$249.7M
Total Assets
$147.8M
$268.1M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
CLFD
CLFD
Q4 25
$78.2M
$96.4M
Q3 25
$58.7M
$106.0M
Q2 25
$66.3M
$117.2M
Q1 25
$59.8M
$112.0M
Q4 24
$73.5M
$113.0M
Q3 24
$90.3M
$129.0M
Q2 24
$73.2M
$123.8M
Q1 24
$85.5M
$142.9M
Total Debt
CDXS
CDXS
CLFD
CLFD
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
$2.2M
Q2 24
$28.4M
$2.1M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
CLFD
CLFD
Q4 25
$50.5M
$249.7M
Q3 25
$38.5M
$256.2M
Q2 25
$55.6M
$264.5M
Q1 25
$49.6M
$265.9M
Q4 24
$66.9M
$267.4M
Q3 24
$73.4M
$275.8M
Q2 24
$61.4M
$274.6M
Q1 24
$79.3M
$279.2M
Total Assets
CDXS
CDXS
CLFD
CLFD
Q4 25
$147.8M
$268.1M
Q3 25
$124.0M
$306.2M
Q2 25
$138.2M
$314.7M
Q1 25
$128.9M
$310.9M
Q4 24
$149.0M
$303.2M
Q3 24
$148.2M
$315.3M
Q2 24
$132.0M
$318.1M
Q1 24
$149.6M
$315.4M
Debt / Equity
CDXS
CDXS
CLFD
CLFD
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
0.01×
Q2 24
0.46×
0.01×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
CLFD
CLFD
Operating Cash FlowLast quarter
$20.1M
$-1.4M
Free Cash FlowOCF − Capex
$19.6M
$-2.4M
FCF MarginFCF / Revenue
50.3%
-7.1%
Capex IntensityCapex / Revenue
1.3%
2.9%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
CLFD
CLFD
Q4 25
$20.1M
$-1.4M
Q3 25
$-7.7M
Q2 25
$-18.0M
$7.9M
Q1 25
$-13.8M
$3.0M
Q4 24
$-16.5M
$7.2M
Q3 24
$-13.0M
$22.2M
Q2 24
$-12.2M
$4.0M
Q1 24
$-7.8M
$-5.7M
Free Cash Flow
CDXS
CDXS
CLFD
CLFD
Q4 25
$19.6M
$-2.4M
Q3 25
$-7.9M
Q2 25
$-20.5M
$7.5M
Q1 25
$-15.1M
$654.0K
Q4 24
$-18.2M
$5.1M
Q3 24
$-14.0M
$18.2M
Q2 24
$-12.6M
$2.8M
Q1 24
$-8.9M
$-7.7M
FCF Margin
CDXS
CDXS
CLFD
CLFD
Q4 25
50.3%
-7.1%
Q3 25
-91.7%
Q2 25
-133.6%
15.1%
Q1 25
-199.6%
1.4%
Q4 24
-85.0%
17.1%
Q3 24
-109.0%
323.0%
Q2 24
-157.5%
5.8%
Q1 24
-52.2%
-20.8%
Capex Intensity
CDXS
CDXS
CLFD
CLFD
Q4 25
1.3%
2.9%
Q3 25
2.1%
2.0%
Q2 25
16.4%
0.8%
Q1 25
16.7%
5.1%
Q4 24
8.3%
7.0%
Q3 24
7.8%
71.4%
Q2 24
5.0%
2.5%
Q1 24
6.6%
5.3%
Cash Conversion
CDXS
CDXS
CLFD
CLFD
Q4 25
2.09×
Q3 25
Q2 25
4.93×
Q1 25
2.30×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons